Optimizing Clinical Care in Patients with Advanced Soft Tissue Sarcoma: A Phase II Study of a New Schedule of High-Dose Continuous Infusion Ifosfamide and Doxorubicin Combination

Publisher： Karger

E-ISSN： 1421-9794|57|3|217-224

ISSN： 0009-3157

Source： Chemotherapy, Vol.57, Iss.3, 2011-05, pp. : 217-224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination of Trabectedin and Gemcitabine for Advanced Soft Tissue Sarcomas: Results of a Phase I Dose Escalating Trial of the German Interdisciplinary Sarcoma Group (GISG)

By Kasper Bernd   Reichardt Peter   Pink Daniel   Sommer Michaela   Mathew Monika   Rauch Geraldine   Hohenberger Peter  

Marine Drugs, Vol. 13, Iss. 1, 2015-01 ,pp. : 379-388

MDPI

Access to resources Recommend Favorite

A Phase I Study of High-Dose Calcitriol in Combination with Temozolomide for Patients with Metastatic Melanoma

By Pettijohn Erin   Martone Brenda   Rademaker Alfred   Kuzel Timothy  

Journal of Personalized Medicine, Vol. 4, Iss. 4, 2014-10 ,pp. : 448-458

MDPI

Access to resources Recommend Favorite

Fixed Dose Rate Infusion of Gemcitabine with Oral Doxifluridine and Leucovorin for Advanced Unresectable Pancreatic Cancer: A Phase II Study

By  

Chemotherapy, Vol. 54, Iss. 1, 2007-12 ,pp. : 54-62

Karger

Access to resources Recommend Favorite

A Phase I Study of Prolonged Ambulatory Infusion of Ifosfamide with Oral Mesna

By  

Chemotherapy, Vol. 51, Iss. 2-3, 2005-06 ,pp. : 142-146

Karger

Access to resources Recommend Favorite

High-Dose Platinum Combination Therapy in Pretreated Patients with Disseminated Melanoma

By  

Chemotherapy, Vol. 53, Iss. 6, 2007-10 ,pp. : 422-428

Karger

Access to resources Recommend Favorite